Business
Tolmar deal sets U.S. path for Alpha DaRT in prostate cancer
The agreement gives Tolmar exclusive U.S. commercialization rights for Alpha DaRT in prostate cancer and includes upfront funding, manufacturing support, and milestone payments.
Company
Alpha Tau Medical